Avalo Therapeutics Inc AVTX Q1 2026 Earnings NarrowerThanExpected Loss Marks Continued Progress for ClinicalStage Biotech
Puma Biotechnology PBYI Q1 2026 Earnings EPS Beats Estimates by Wide Margin Shares Rise
DSGR Q1 2026 Earnings EPS Beats Estimates Despite Modest Stock Decline
FCAP Q1 2026 Earnings Solid EPS of 130 Drives Modest Stock Gain
FMBH Q1 2026 Earnings EPS Surpasses Expectations Stock Moves Lower
UNP Q1 2026 Earnings EPS Beats Estimates Amid Strong Operational Performance